Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Polypeptide Drug market report explains the definition, types, applications, major countries, and major players of the Polypeptide Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
SciClone Pharmaceuticals
Lilly
Roche
Merck Serono
Novartis
Ipsen PHarma Biotech
AstraZeneca
Ferring Pharmaceuticals
Sanofi
Asahi Kasei
Takeda
By Type:
Injection
Nasal administration
Lung administration
Oral administration
Transdermal administration
By End-User:
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Polypeptide Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Polypeptide Drug Outlook to 2028- Original Forecasts
-
2.2 Polypeptide Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Polypeptide Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Polypeptide Drug Market- Recent Developments
-
6.1 Polypeptide Drug Market News and Developments
-
6.2 Polypeptide Drug Market Deals Landscape
7 Polypeptide Drug Raw Materials and Cost Structure Analysis
-
7.1 Polypeptide Drug Key Raw Materials
-
7.2 Polypeptide Drug Price Trend of Key Raw Materials
-
7.3 Polypeptide Drug Key Suppliers of Raw Materials
-
7.4 Polypeptide Drug Market Concentration Rate of Raw Materials
-
7.5 Polypeptide Drug Cost Structure Analysis
-
7.5.1 Polypeptide Drug Raw Materials Analysis
-
7.5.2 Polypeptide Drug Labor Cost Analysis
-
7.5.3 Polypeptide Drug Manufacturing Expenses Analysis
8 Global Polypeptide Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Polypeptide Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Polypeptide Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Polypeptide Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Polypeptide Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Nasal administration Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lung administration Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Oral administration Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Transdermal administration Consumption and Growth Rate (2017-2022)
-
9.2 Global Polypeptide Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Digestive System Drugs (Gastrointestinal Type) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Gynecologic or Obstetric Drug Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Tumor Drug Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Urinary System Drug Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Polypeptide Drug Market Analysis and Outlook till 2022
-
10.1 Global Polypeptide Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Polypeptide Drug Consumption (2017-2022)
-
10.2.2 Canada Polypeptide Drug Consumption (2017-2022)
-
10.2.3 Mexico Polypeptide Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Polypeptide Drug Consumption (2017-2022)
-
10.3.2 UK Polypeptide Drug Consumption (2017-2022)
-
10.3.3 Spain Polypeptide Drug Consumption (2017-2022)
-
10.3.4 Belgium Polypeptide Drug Consumption (2017-2022)
-
10.3.5 France Polypeptide Drug Consumption (2017-2022)
-
10.3.6 Italy Polypeptide Drug Consumption (2017-2022)
-
10.3.7 Denmark Polypeptide Drug Consumption (2017-2022)
-
10.3.8 Finland Polypeptide Drug Consumption (2017-2022)
-
10.3.9 Norway Polypeptide Drug Consumption (2017-2022)
-
10.3.10 Sweden Polypeptide Drug Consumption (2017-2022)
-
10.3.11 Poland Polypeptide Drug Consumption (2017-2022)
-
10.3.12 Russia Polypeptide Drug Consumption (2017-2022)
-
10.3.13 Turkey Polypeptide Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Polypeptide Drug Consumption (2017-2022)
-
10.4.2 Japan Polypeptide Drug Consumption (2017-2022)
-
10.4.3 India Polypeptide Drug Consumption (2017-2022)
-
10.4.4 South Korea Polypeptide Drug Consumption (2017-2022)
-
10.4.5 Pakistan Polypeptide Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Polypeptide Drug Consumption (2017-2022)
-
10.4.7 Indonesia Polypeptide Drug Consumption (2017-2022)
-
10.4.8 Thailand Polypeptide Drug Consumption (2017-2022)
-
10.4.9 Singapore Polypeptide Drug Consumption (2017-2022)
-
10.4.10 Malaysia Polypeptide Drug Consumption (2017-2022)
-
10.4.11 Philippines Polypeptide Drug Consumption (2017-2022)
-
10.4.12 Vietnam Polypeptide Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Polypeptide Drug Consumption (2017-2022)
-
10.5.2 Colombia Polypeptide Drug Consumption (2017-2022)
-
10.5.3 Chile Polypeptide Drug Consumption (2017-2022)
-
10.5.4 Argentina Polypeptide Drug Consumption (2017-2022)
-
10.5.5 Venezuela Polypeptide Drug Consumption (2017-2022)
-
10.5.6 Peru Polypeptide Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Polypeptide Drug Consumption (2017-2022)
-
10.5.8 Ecuador Polypeptide Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Polypeptide Drug Consumption (2017-2022)
-
10.6.2 Kuwait Polypeptide Drug Consumption (2017-2022)
-
10.6.3 Oman Polypeptide Drug Consumption (2017-2022)
-
10.6.4 Qatar Polypeptide Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Polypeptide Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Polypeptide Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Polypeptide Drug Consumption (2017-2022)
-
10.7.2 South Africa Polypeptide Drug Consumption (2017-2022)
-
10.7.3 Egypt Polypeptide Drug Consumption (2017-2022)
-
10.7.4 Algeria Polypeptide Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Polypeptide Drug Consumption (2017-2022)
-
10.8.2 New Zealand Polypeptide Drug Consumption (2017-2022)
11 Global Polypeptide Drug Competitive Analysis
-
11.1 SciClone Pharmaceuticals
-
11.1.1 SciClone Pharmaceuticals Company Details
-
11.1.2 SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 SciClone Pharmaceuticals Polypeptide Drug Main Business and Markets Served
-
11.1.4 SciClone Pharmaceuticals Polypeptide Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Lilly
-
11.2.1 Lilly Company Details
-
11.2.2 Lilly Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Lilly Polypeptide Drug Main Business and Markets Served
-
11.2.4 Lilly Polypeptide Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Roche
-
11.3.1 Roche Company Details
-
11.3.2 Roche Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Roche Polypeptide Drug Main Business and Markets Served
-
11.3.4 Roche Polypeptide Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Merck Serono
-
11.4.1 Merck Serono Company Details
-
11.4.2 Merck Serono Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Merck Serono Polypeptide Drug Main Business and Markets Served
-
11.4.4 Merck Serono Polypeptide Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novartis
-
11.5.1 Novartis Company Details
-
11.5.2 Novartis Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novartis Polypeptide Drug Main Business and Markets Served
-
11.5.4 Novartis Polypeptide Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Ipsen PHarma Biotech
-
11.6.1 Ipsen PHarma Biotech Company Details
-
11.6.2 Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Ipsen PHarma Biotech Polypeptide Drug Main Business and Markets Served
-
11.6.4 Ipsen PHarma Biotech Polypeptide Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 AstraZeneca
-
11.7.1 AstraZeneca Company Details
-
11.7.2 AstraZeneca Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 AstraZeneca Polypeptide Drug Main Business and Markets Served
-
11.7.4 AstraZeneca Polypeptide Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Ferring Pharmaceuticals
-
11.8.1 Ferring Pharmaceuticals Company Details
-
11.8.2 Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Ferring Pharmaceuticals Polypeptide Drug Main Business and Markets Served
-
11.8.4 Ferring Pharmaceuticals Polypeptide Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Sanofi
-
11.9.1 Sanofi Company Details
-
11.9.2 Sanofi Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Sanofi Polypeptide Drug Main Business and Markets Served
-
11.9.4 Sanofi Polypeptide Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Asahi Kasei
-
11.10.1 Asahi Kasei Company Details
-
11.10.2 Asahi Kasei Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Asahi Kasei Polypeptide Drug Main Business and Markets Served
-
11.10.4 Asahi Kasei Polypeptide Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Takeda
-
11.11.1 Takeda Company Details
-
11.11.2 Takeda Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Takeda Polypeptide Drug Main Business and Markets Served
-
11.11.4 Takeda Polypeptide Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Polypeptide Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Polypeptide Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Nasal administration Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Lung administration Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Oral administration Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Transdermal administration Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Polypeptide Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Digestive System Drugs (Gastrointestinal Type) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Gynecologic or Obstetric Drug Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Urinary System Drug Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Polypeptide Drug Market Analysis and Outlook to 2028
-
13.1 Global Polypeptide Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Polypeptide Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Polypeptide Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.5 France Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Polypeptide Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.3 India Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Polypeptide Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Polypeptide Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Polypeptide Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Polypeptide Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Polypeptide Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Polypeptide Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Polypeptide Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Polypeptide Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Polypeptide Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Polypeptide Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Polypeptide Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Polypeptide Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Polypeptide Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Polypeptide Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Polypeptide Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Polypeptide Drug
-
Figure of Polypeptide Drug Picture
-
Table Global Polypeptide Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Polypeptide Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Nasal administration Consumption and Growth Rate (2017-2022)
-
Figure Global Lung administration Consumption and Growth Rate (2017-2022)
-
Figure Global Oral administration Consumption and Growth Rate (2017-2022)
-
Figure Global Transdermal administration Consumption and Growth Rate (2017-2022)
-
Figure Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption and Growth Rate (2017-2022)
-
Figure Global Digestive System Drugs (Gastrointestinal Type) Consumption and Growth Rate (2017-2022)
-
Figure Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption and Growth Rate (2017-2022)
-
Figure Global Gynecologic or Obstetric Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Urinary System Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption and Growth Rate (2017-2022)
-
Figure Global Polypeptide Drug Consumption by Country (2017-2022)
-
Table North America Polypeptide Drug Consumption by Country (2017-2022)
-
Figure United States Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Polypeptide Drug Consumption by Country (2017-2022)
-
Figure Germany Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure France Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Polypeptide Drug Consumption by Country (2017-2022)
-
Figure China Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure India Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table South America Polypeptide Drug Consumption by Country (2017-2022)
-
Figure Brazil Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Polypeptide Drug Consumption by Country (2017-2022)
-
Figure Bahrain Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Polypeptide Drug Consumption by Country (2017-2022)
-
Figure Nigeria Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Polypeptide Drug Consumption by Country (2017-2022)
-
Figure Australia Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Polypeptide Drug Consumption and Growth Rate (2017-2022)
-
Table SciClone Pharmaceuticals Company Details
-
Table SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table SciClone Pharmaceuticals Polypeptide Drug Main Business and Markets Served
-
Table SciClone Pharmaceuticals Polypeptide Drug Product Portfolio
-
Table Lilly Company Details
-
Table Lilly Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lilly Polypeptide Drug Main Business and Markets Served
-
Table Lilly Polypeptide Drug Product Portfolio
-
Table Roche Company Details
-
Table Roche Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Polypeptide Drug Main Business and Markets Served
-
Table Roche Polypeptide Drug Product Portfolio
-
Table Merck Serono Company Details
-
Table Merck Serono Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Serono Polypeptide Drug Main Business and Markets Served
-
Table Merck Serono Polypeptide Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Polypeptide Drug Main Business and Markets Served
-
Table Novartis Polypeptide Drug Product Portfolio
-
Table Ipsen PHarma Biotech Company Details
-
Table Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen PHarma Biotech Polypeptide Drug Main Business and Markets Served
-
Table Ipsen PHarma Biotech Polypeptide Drug Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Polypeptide Drug Main Business and Markets Served
-
Table AstraZeneca Polypeptide Drug Product Portfolio
-
Table Ferring Pharmaceuticals Company Details
-
Table Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Pharmaceuticals Polypeptide Drug Main Business and Markets Served
-
Table Ferring Pharmaceuticals Polypeptide Drug Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Polypeptide Drug Main Business and Markets Served
-
Table Sanofi Polypeptide Drug Product Portfolio
-
Table Asahi Kasei Company Details
-
Table Asahi Kasei Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Asahi Kasei Polypeptide Drug Main Business and Markets Served
-
Table Asahi Kasei Polypeptide Drug Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Polypeptide Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Polypeptide Drug Main Business and Markets Served
-
Table Takeda Polypeptide Drug Product Portfolio
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nasal administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transdermal administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunity Regulating Medicine (Allergy Infection and Immune) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Digestive System Drugs (Gastrointestinal Type) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone and Connective Tissue Types (Thyroid hormones Drug) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gynecologic or Obstetric Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urinary System Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Table North America Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure China Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Polypeptide Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Polypeptide Drug Consumption Forecast and Growth Rate (2022-2028)
-
